Lexeo Therapeutics Inc (NASDAQ: LXEO) on Tuesday, plunged -5.16% from the previous trading day, before settling in for the closing price of $10.27. Within the past 52 weeks, LXEO’s price has moved between $1.45 and $10.99.
Healthcare Sector giant saw their annual sales slid by -99.98% over the last five years. The company achieved an average annual earnings per share of 37.04%. With a float of $60.28 million, this company’s outstanding shares have now reached $72.99 million.
Lexeo Therapeutics Inc (LXEO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Lexeo Therapeutics Inc is 17.40%, while institutional ownership is 77.27%. The most recent insider transaction that took place on Nov 18 ’25, was worth 10,447. In this transaction Chief Executive Officer of this company sold 1,127 shares at a rate of $9.27, taking the stock ownership to the 240,991 shares. Before that another transaction happened on Nov 18 ’25, when Company’s Chief Medical Officer sold 615 for $9.27, making the entire transaction worth $5,701. This insider now owns 72,646 shares in total.
Lexeo Therapeutics Inc (LXEO) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.78 earnings per share (EPS) for the period topping the consensus outlook (set at -0.78) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.95% during the next five years compared to -99.98% drop over the previous five years of trading.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Lexeo Therapeutics Inc (LXEO) is currently performing well based on its current performance indicators. A quick ratio of 7.40 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Analysing the last 5-days average volume posted by the [Lexeo Therapeutics Inc, LXEO], we can find that recorded value of 0.6 million was lower than the volume posted last year of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 53.68%.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 81.24%, which indicates a significant increase from 35.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.62 in the past 14 days, which was higher than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.42, while its 200-day Moving Average is $5.63. Now, the first resistance to watch is $10.12. This is followed by the second major resistance level at $10.49. The third major resistance level sits at $10.72. If the price goes on to break the first support level at $9.51, it is likely to go to the next support level at $9.28. Now, if the price goes above the second support level, the third support stands at $8.91.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
Market capitalization of the company is 710.90 million based on 72,987K outstanding shares. Right now, sales total 0 K and income totals -98,330 K. The company made 0 K in profit during its latest quarter, and -20,280 K in sales during its previous quarter.
